[Ip-health] RCEP trade deal and concerns regarding access to medicines

leena menghaney leenamenghaney at gmail.com
Fri Jul 28 05:26:31 PDT 2017


Please find below Opinion Pieces published on RCEP during the Hyderabad
(India) round of negotiations which highlight the concerns around
affordable medicines.


Trading away health,
Rohit Malpani, The Hindu
http://www.thehindu.com/sci-tech/health/trading-away-health/article19333287.ece

Out-of-Sight RCEP Negotiations Threaten Public Health and Access to
Medicines
Tahir Amin, The Wire
https://thewire.in/161323/rcep-negotiations-healthcare-medicines/

RCEP deal could spell bad news for public health in India
Leena Menghaney, Huffington Post
http://www.huffingtonpost.in/medecins-sans-frontieres-msf/rcep-deal-could-spell-bad-news-for-public-health-in-india-and-be_a_23040583/

No logic in extending length of patents
Feroz Ali, Live Mint
http://www.livemint.com/Opinion/Um6bAhciFROYN88hqmXt4L/No-logic-in-extending-length-of-patents.html

What’s at stake in Hyderabad
Feroz Ali, The Hindu
http://www.thehindu.com/opinion/op-ed/whats-at-stake-in-hyderabad/article19372743.ece

A Trade Deal Could Hit Affordable & Generic Medicines in India. Here’s What
You Need to Know
Doctors Without Borders, The Better India
http://www.thebetterindia.com/109557/rcep-trade-deal-generic-medicine-india-healthcare/

Leena Menghaney, MSF Access Campaign, New Delhi, #9811365412




--
Leena Menghaney
Mobile: 9811365412



More information about the Ip-health mailing list